Sec. 562.153.  REQUIREMENTS FOR OFFICE USE COMPOUNDING.  To dispense and deliver a compounded drug under Section 562.152, a pharmacy must:
(1)  verify the source of the raw materials to be used in a compounded drug;
(2)  comply with applicable United States Pharmacopoeia guidelines, including the testing requirements, and the Health Insurance Portability and Accountability Act of 1996 (Pub. L. No. 104-191);
(3)  comply with all applicable competency and accrediting standards as determined by the board; and
(4)  comply with board rules, including rules regarding the reporting of adverse events by practitioners and recall procedures for compounded products.
Amended by: 
Acts 2005, 79th Leg., Ch. 28 (S.B. 492), Sec. 4, eff. September 1, 2005.